Artificial Intelligence to offer worthwhile breakthroughs in the medical sector

The team has come up with a new AI technology-based heart imaging called Virtual Native Enhancement (VNE) that can elevate patient’s care along with helping the doctors to inspect through their hearts for scar tissue. The new technology, furthermore, eliminates the necessity of contrast injections that are required in traditional CMR. The team published its success article in the scientific journal Circulation. CMR is used for hypertrophic cardiomyopathy, one of the most common genetic heart conditions. The researchers discovered that VNE provides images with high quality and captures evidence of scar in the heart. Moreover, the process can help CMR scans to be done easily without injecting the standard contrast agent required in CMR along with offering low-cost services.

Another such invention is under processing carrying out by the researchers at the University of Oxford. The researchers are working on bringing up an AI-based COVID screening test. As a result, the researchers have brought up a CURIAL Rapid test that can be helpful for patients in the emergency department. The results of this ten minutes test can be generated within 45 minutes which is 26% faster than the lateral flow test. Over the PCR testing, the AI test is more prospective in identifying COVID patients.
Apart from this, the companies are also initiating partnerships and mergers to develop advanced solutions. Lately, Beeline, a mobile operator of Amsterdam-based leading connectivity and internet services provider VEON, has collaborated with Sechenov Medical University in Russia for using AI technology in diagnostic medicine. The partnership aims to develop neural network pattern-matching algorithms for the early detection of kidney disease, potential cancer, and damage in hip joints.
The impact of AI has been huge in our lives. And medical sector presently requires more advanced solutions and strong technologies. The implementation of AI in upcoming medical technologies, therefore, unlocks huge potential for the market players. Undeniably, the industry faces certain challenges including limitations based on AI decision-making and acceptance of these technologies by healthcare professionals. But despite that, the market is expected to bring upon the latest innovations in the future. According to a report published by Allied Market Research, the global artificial intelligence in the medicines market is estimated to garner $18.11 billion.
The processing power of AI systems is enhancing AI capabilities. Also, the lack of skilled healthcare professionals and the growing importance of precision medicine is leading to the demand for AI-based medical technologies. At the same time, the market players are approaching with new plans and policies. The further research and development procedures for advanced AI technology-based solutions and devices are unfolding opportunities for the market players. Also, the untapped market in emerging economies is expected to offer huge prospects to the industry. And with all these aspects, the industry is projected to rise significantly in the coming years.